179 related articles for article (PubMed ID: 8724036)
1. Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120.
Pittaluga A; Pattarini R; Severi P; Raiteri M
AIDS; 1996 May; 10(5):463-8. PubMed ID: 8724036
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 envelope protein gp120 potentiates NMDA-evoked noradrenaline release by a direct action at rat hippocampal and cortical noradrenergic nerve endings.
Pittaluga A; Raiteri M
Eur J Neurosci; 1994 Nov; 6(11):1743-9. PubMed ID: 7874313
[TBL] [Abstract][Full Text] [Related]
3. The human immunodeficiency virus-1 envelope protein gp120 binds through its V3 sequence to the glycine site of N-methyl-D-aspartate receptors mediating noradrenaline release in the hippocampus.
Pattarini R; Pittaluga A; Raiteri M
Neuroscience; 1998 Nov; 87(1):147-57. PubMed ID: 9722148
[TBL] [Abstract][Full Text] [Related]
4. The HIV-1 coat protein gp120 and some of its fragments potently activate native cerebral NMDA receptors mediating neuropeptide release.
Gemignani A; Paudice P; Pittaluga A; Raiteri M
Eur J Neurosci; 2000 Aug; 12(8):2839-46. PubMed ID: 10971626
[TBL] [Abstract][Full Text] [Related]
5. N-methyl-D-aspartate receptors mediating hippocampal noradrenaline and striatal dopamine release display differential sensitivity to quinolinic acid, the HIV-1 envelope protein gp120, external pH and protein kinase C inhibition.
Pittaluga A; Pattarini R; Feligioni M; Raiteri M
J Neurochem; 2001 Jan; 76(1):139-48. PubMed ID: 11145986
[TBL] [Abstract][Full Text] [Related]
6. Gp120 can revert antagonism at the glycine site of NMDA receptors mediating GABA release from cultured hippocampal neurons.
Fontana G; Valenti L; Raiteri M
J Neurosci Res; 1997 Sep; 49(6):732-8. PubMed ID: 9335260
[TBL] [Abstract][Full Text] [Related]
7. Effect of 1-aminocyclopropanecarboxylic acid on N-methyl-D-aspartate-stimulated [3H]-noradrenaline release in rat hippocampal synaptosomes.
Clos MV; Garcia Sanz A; Trullas R; Badia A
Br J Pharmacol; 1996 Jun; 118(4):901-4. PubMed ID: 8799560
[TBL] [Abstract][Full Text] [Related]
8. Endogenous glycine modulates N-methyl-D-aspartate-evoked release of adenosine and [3H]noradrenaline from rat cortical slices.
Craig CG; White TD
Eur J Pharmacol; 1991 May; 197(1):1-7. PubMed ID: 1832638
[TBL] [Abstract][Full Text] [Related]
9. GV 150526A, 7-Cl-kynurenic acid and HA 966 antagonize the glycine enhancement of N-methyl-D-aspartate-induced [3H]noradrenaline and [3H]dopamine release.
Mennini T; Mancini L; Reggiani A; Trist D
Eur J Pharmacol; 1997 Oct; 336(2-3):275-81. PubMed ID: 9384243
[TBL] [Abstract][Full Text] [Related]
10. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.
Luccini E; Musante V; Neri E; Raiteri M; Pittaluga A
J Neurosci Res; 2007 Dec; 85(16):3657-65. PubMed ID: 17671992
[TBL] [Abstract][Full Text] [Related]
11. Functional interactions between presynaptic NMDA receptors and metabotropic glutamate receptors co-expressed on rat and human noradrenergic terminals.
Luccini E; Musante V; Neri E; Brambilla Bas M; Severi P; Raiteri M; Pittaluga A
Br J Pharmacol; 2007 Aug; 151(7):1087-94. PubMed ID: 17592518
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors.
Fink K; Schultheiss R; Göthert M
Br J Pharmacol; 1992 May; 106(1):67-72. PubMed ID: 1380384
[TBL] [Abstract][Full Text] [Related]
13. The human immunodeficiency virus-1 protein transactivator of transcription up-regulates N-methyl-D-aspartate receptor function by acting at metabotropic glutamate receptor 1 receptors coexisting on human and rat brain noradrenergic neurones.
Longordo F; Feligioni M; Chiaramonte G; Sbaffi PF; Raiteri M; Pittaluga A
J Pharmacol Exp Ther; 2006 Jun; 317(3):1097-105. PubMed ID: 16489129
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of noradrenaline release in the cerebral cortex via presynaptic N-methyl-D-aspartate (NMDA) receptors and their pharmacological characterization.
Göthert M; Fink K
J Neural Transm Suppl; 1991; 34():121-7. PubMed ID: 1687781
[TBL] [Abstract][Full Text] [Related]
15. Glycine site antagonists and partial agonists inhibit N-methyl-D-aspartate receptor-mediated [3H]arachidonic acid release in cerebellar granule cells.
Viu E; Zapata A; Capdevila JL; Fossom LH; Skolnick P; Trullas R
J Pharmacol Exp Ther; 1998 May; 285(2):527-32. PubMed ID: 9580593
[TBL] [Abstract][Full Text] [Related]
16. Putative cognition enhancers reverse kynurenic acid antagonism at hippocampal NMDA receptors.
Pittaluga A; Pattarini R; Raiteri M
Eur J Pharmacol; 1995 Jan; 272(2-3):203-9. PubMed ID: 7713164
[TBL] [Abstract][Full Text] [Related]
17. N-methyl-D-aspartate (NMDA)-stimulated noradrenaline (NA) release in rat brain cortex is modulated by presynaptic H3-receptors.
Fink K; Schlicker E; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1994 Feb; 349(2):113-7. PubMed ID: 8170496
[TBL] [Abstract][Full Text] [Related]
18. N-methyl-D-aspartate (NMDA) receptor-mediated stimulation of noradrenaline release, but not release of other neurotransmitters, in the rat brain cortex: receptor location, characterization and desensitization.
Fink K; Göthert M; Molderings G; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):514-21. PubMed ID: 2570360
[TBL] [Abstract][Full Text] [Related]
19. N-methyl-D-aspartic acid/glycine interactions on the control of 5-hydroxytryptamine release in raphe primary cultures.
Becquet D; Héry M; Deprez P; Faudon M; Fache MP; Giraud P; Héry F
J Neurochem; 1993 Nov; 61(5):1692-7. PubMed ID: 7901329
[TBL] [Abstract][Full Text] [Related]
20. Taurine potentiates presynaptic NMDA receptors in hippocampal Schaffer collateral axons.
Suárez LM; Solís JM
Eur J Neurosci; 2006 Jul; 24(2):405-18. PubMed ID: 16836643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
